Iran vs Turkmenistan: Immunization, Hib3 (% of children ages 12-23 months)
Iran
98.0%
in 2024
Turkmenistan
98.0%
in 2024
Iran rank
20th
Turkmenistan rank
20th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Iran
- Turkmenistan
How they compare
Iran currently reports 98.0% against 98.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2015 it was Turkmenistan ahead.
Iran ranks 20th and Turkmenistan ranks 20th of 191 countries.
Iran has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.8% | 98.8% | 0.0% | — |
| 2020s | 98.6% | 98.0% | 0.6% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Iran or Turkmenistan?
- Iran, at 98.0% against 98.0% in Turkmenistan as of 2024.
- What is the difference in immunization, hib3 between Iran and Turkmenistan?
- 0.0%, with Iran ahead.
- How many years of comparable data are there for Iran and Turkmenistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Iran and Turkmenistan rank globally for immunization, hib3?
- Iran ranks 20th and Turkmenistan ranks 20th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.